ACS Infectious Diseases最新文献

筛选
英文 中文
Whole-Cell Study Unveils Critical Mechanistic Elements, Regulatory Elements, and Inhibitor Targets of the Mycobacterium abscessus Cytochrome bd Oxidase.
IF 4 2区 医学
ACS Infectious Diseases Pub Date : 2025-04-08 DOI: 10.1021/acsinfecdis.5c00092
Vikneswaran Mathiyazakan, Subha Suvetha Kathalingam, Wan Ni Pok, Ria Sorayah, Kevin Pethe, Gerhard Grüber
{"title":"Whole-Cell Study Unveils Critical Mechanistic Elements, Regulatory Elements, and Inhibitor Targets of the <i>Mycobacterium abscessus</i> Cytochrome <i>bd</i> Oxidase.","authors":"Vikneswaran Mathiyazakan, Subha Suvetha Kathalingam, Wan Ni Pok, Ria Sorayah, Kevin Pethe, Gerhard Grüber","doi":"10.1021/acsinfecdis.5c00092","DOIUrl":"https://doi.org/10.1021/acsinfecdis.5c00092","url":null,"abstract":"<p><p>The nontuberculous mycobacterium (NTM) <i>Mycobacterium abscessus</i> (<i>Mab</i>) has emerged as a global health concern due to its high intrinsic resistance toward antibiotics. The search for anti-NTM inhibitors requires novel well-characterized targets. The cytochrome <i>bd</i> (cyt-<i>bd</i>) oxidase, which serves as an alternate terminal oxidase in mycobacteria, is a chemically validated drug target in <i>Mycobacterium tuberculosis</i> <i>(Mtb)</i>. However, no genetic, biochemical, or structural studies have been described for the <i>Mab</i> enzyme. Successful targeting of the <i>Mab</i> cyt-<i>bd</i> oxidase requires an in-depth understanding of its mechanistic and regulatory elements. Here, we generated a homology model of <i>Mab</i> cyt-<i>bd</i>, including the alternate menaquinol-binding pocket, the predicted oxygen channel, the proposed redox modulation site (C266-C285), and the salt bridge pair, keeping the cysteine residues in proximity. A heterologous system was developed for whole-cell functional studies to characterize the impact of mutations in these critical domains on enzyme activity. Mutating W9, E98, F103, or E263 to alanine inhibited the enzyme totally, underscoring their importance in menaquinol binding, oxygen reduction, and/or redox modulation. The <i>Mab</i> cyt-<i>bd</i> C285A mutant displayed a reduction in oxygen consumption and ATP formation, a phenomenon also presented for the <i>Mtb</i> C285A mutant. In summary, this study presents the first structural and biochemical characterization of <i>Mab</i> cyt-<i>bd</i> oxidase, providing insights into the importance of mechanistic and regulatory elements of the <i>Mab</i> enzyme in a whole-cell setup, which will be of relevance for the design of anti-NTM and antituberculosis hit molecules targeting this oxidase.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143802004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conservation of Putative Liquid-Liquid Phase Separating Proteins in Multiple Drug-Resistant Mycobacterium tuberculosis: Role in Host-Pathogen Interactions?
IF 4 2区 医学
ACS Infectious Diseases Pub Date : 2025-04-04 DOI: 10.1021/acsinfecdis.4c00722
Jasdeep Singh, Prashant Pradhan, Arti Kataria, Sanjeev Sinha, Nasreen Z Ehtesham, Peter N Monk, Seyed E Hasnain
{"title":"Conservation of Putative Liquid-Liquid Phase Separating Proteins in Multiple Drug-Resistant <i>Mycobacterium tuberculosis</i>: Role in Host-Pathogen Interactions?","authors":"Jasdeep Singh, Prashant Pradhan, Arti Kataria, Sanjeev Sinha, Nasreen Z Ehtesham, Peter N Monk, Seyed E Hasnain","doi":"10.1021/acsinfecdis.4c00722","DOIUrl":"https://doi.org/10.1021/acsinfecdis.4c00722","url":null,"abstract":"<p><p>We observed a high proportion of proteins in pathogenic <i>Mycobacterium</i> species that can potentially undergo liquid-liquid phase separation (LLPS) mediated biomolecular condensate formation, compared to nonpathogenic species. These proteins mainly include the PE-PPE and PE-PGRS families of proteins that have nucleic acid and protein-protein binding functions, typical of LLPS proteins. We also mapped identified LLPS proteins in <i>M. tuberculosis</i> (M.tb) drug-resistant databases PubMLST and TBProfiler, based upon the WHO 2023 catalogue of resistance-associated mutations. High sequence conservation of LLPS-associated proteins in various multiple drug-resistant M.tb isolates points to their potentially important role in virulence and host-pathogen interactions during pathogenic evolution. This analysis provides a perspective on the role of protein phase separation in the evaluation of M.tb pathogenesis and offers avenues for future research aimed at developing innovative strategies to combat M.tb infection.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143778596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of the Orphan Cytochrome P450 CYP135B1 from Mycobacterium tuberculosis: Involvement in Metabolism but Not in the Antibacterial Activity of the Antitubercular Drug SQ109
IF 4 2区 医学
ACS Infectious Diseases Pub Date : 2025-04-02 DOI: 10.1021/acsinfecdis.4c0089310.1021/acsinfecdis.4c00893
Elodie Sadowski, Nicolas Pietrancosta, Romain Veyron-Churlet, Jean-Luc Boucher, Cédric Pionneau, Gilles Clodic, Lucrèce Matheron, Olivier Poch, Claudine Mayer, Emmanuelle Sachon* and Alexandra Aubry*, 
{"title":"Characterization of the Orphan Cytochrome P450 CYP135B1 from Mycobacterium tuberculosis: Involvement in Metabolism but Not in the Antibacterial Activity of the Antitubercular Drug SQ109","authors":"Elodie Sadowski,&nbsp;Nicolas Pietrancosta,&nbsp;Romain Veyron-Churlet,&nbsp;Jean-Luc Boucher,&nbsp;Cédric Pionneau,&nbsp;Gilles Clodic,&nbsp;Lucrèce Matheron,&nbsp;Olivier Poch,&nbsp;Claudine Mayer,&nbsp;Emmanuelle Sachon* and Alexandra Aubry*,&nbsp;","doi":"10.1021/acsinfecdis.4c0089310.1021/acsinfecdis.4c00893","DOIUrl":"https://doi.org/10.1021/acsinfecdis.4c00893https://doi.org/10.1021/acsinfecdis.4c00893","url":null,"abstract":"<p >The rise of multidrug-resistant tuberculosis (TB) has increased the need for new antitubercular (anti-TB) drugs and the identification of novel drug targets. One promising target is <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) cytochrome P450 enzymes (P450s). This study focuses on the characterization of CYP135B1, a prevalent <i>Mtb</i> P450. Using a combination of microbiology, genomics, bioinformatics, docking, spectroscopy, and mass spectrometry, researchers successfully expressed, purified, and characterized CYP135B1. A 3D model was built with AlphaFold 3. The enzyme displayed typical features of P450 proteins and showed strong binding to imidazole derivatives. Notably, CYP135B1 metabolized the anti-TB drug SQ109 by inserting oxygen into its geranyl moiety in a manner distinct from CYP124A1. However, genetic studies using a ΔCYP135B1 mutant strain revealed that CYP135B1 is not required for SQ109’s antibacterial activity, as its deletion did not affect drug efficacy despite CYP135B1 metabolizes SQ109.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"11 4","pages":"869–881 869–881"},"PeriodicalIF":4.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143814651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of the Orphan Cytochrome P450 CYP135B1 from Mycobacterium tuberculosis: Involvement in Metabolism but Not in the Antibacterial Activity of the Antitubercular Drug SQ109.
IF 4 2区 医学
ACS Infectious Diseases Pub Date : 2025-04-02 DOI: 10.1021/acsinfecdis.4c00893
Elodie Sadowski, Nicolas Pietrancosta, Romain Veyron-Churlet, Jean-Luc Boucher, Cédric Pionneau, Gilles Clodic, Lucrèce Matheron, Olivier Poch, Claudine Mayer, Emmanuelle Sachon, Alexandra Aubry
{"title":"Characterization of the Orphan Cytochrome P450 CYP135B1 from <i>Mycobacterium tuberculosis</i>: Involvement in Metabolism but Not in the Antibacterial Activity of the Antitubercular Drug SQ109.","authors":"Elodie Sadowski, Nicolas Pietrancosta, Romain Veyron-Churlet, Jean-Luc Boucher, Cédric Pionneau, Gilles Clodic, Lucrèce Matheron, Olivier Poch, Claudine Mayer, Emmanuelle Sachon, Alexandra Aubry","doi":"10.1021/acsinfecdis.4c00893","DOIUrl":"https://doi.org/10.1021/acsinfecdis.4c00893","url":null,"abstract":"<p><p>The rise of multidrug-resistant tuberculosis (TB) has increased the need for new antitubercular (anti-TB) drugs and the identification of novel drug targets. One promising target is <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) cytochrome P450 enzymes (P450s). This study focuses on the characterization of CYP135B1, a prevalent <i>Mtb</i> P450. Using a combination of microbiology, genomics, bioinformatics, docking, spectroscopy, and mass spectrometry, researchers successfully expressed, purified, and characterized CYP135B1. A 3D model was built with AlphaFold 3. The enzyme displayed typical features of P450 proteins and showed strong binding to imidazole derivatives. Notably, CYP135B1 metabolized the anti-TB drug SQ109 by inserting oxygen into its geranyl moiety in a manner distinct from CYP124A1. However, genetic studies using a ΔCYP135B1 mutant strain revealed that CYP135B1 is not required for SQ109's antibacterial activity, as its deletion did not affect drug efficacy despite CYP135B1 metabolizes SQ109.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143770698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Honoring Robert E. W. Hancock: A Legacy of Innovation in Microbiology and Infectious Disease Research.
IF 4 2区 医学
ACS Infectious Diseases Pub Date : 2025-04-01 DOI: 10.1021/acsinfecdis.5c00207
Cesar de la Fuente-Nunez, Jayanta Haldar
{"title":"Honoring Robert E. W. Hancock: A Legacy of Innovation in Microbiology and Infectious Disease Research.","authors":"Cesar de la Fuente-Nunez, Jayanta Haldar","doi":"10.1021/acsinfecdis.5c00207","DOIUrl":"https://doi.org/10.1021/acsinfecdis.5c00207","url":null,"abstract":"","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143762628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SIRT1 and SIRT3 Impact Host Mitochondrial Function and Host Salmonella pH Balance during Infection.
IF 4 2区 医学
ACS Infectious Diseases Pub Date : 2025-04-01 DOI: 10.1021/acsinfecdis.4c00751
Dipasree Hajra, Vikas Yadav, Amit Singh, Dipshikha Chakravortty
{"title":"SIRT1 and SIRT3 Impact Host Mitochondrial Function and Host <i>Salmonella</i> pH Balance during Infection.","authors":"Dipasree Hajra, Vikas Yadav, Amit Singh, Dipshikha Chakravortty","doi":"10.1021/acsinfecdis.4c00751","DOIUrl":"https://doi.org/10.1021/acsinfecdis.4c00751","url":null,"abstract":"<p><p>Mitochondria are important organelles that regulate energy homeostasis. Mitochondrial health and dynamics are crucial determinants of the outcome of several bacterial infections. SIRT3, a major mitochondrial sirtuin, along with SIRT1 regulates key mitochondrial functions. This led to considerable interest in understanding the role of SIRT1 and SIRT3 in governing mitochondrial functions during <i>Salmonella</i> infection. Here, we show that loss of SIRT1 and SIRT3 function either by shRNA-mediated knockdown or by inhibitor treatment led to increased mitochondrial dysfunction with alteration in mitochondrial bioenergetics alongside increased mitochondrial superoxide generation in <i>Salmonella-</i>infected macrophages. Consistent with dysfunctional mitochondria, mitophagy was induced along with altered mitochondrial fusion-fission dynamics in <i>S. typhimurium</i><i>-</i>infected macrophages. Additionally, the mitochondrial bioenergetic alteration promotes acidification of the infected macrophage cytosolic pH. This host cytosolic pH imbalance skewed the intraphagosomal and intrabacterial pH in the absence of SIRT1 and SIRT3, resulting in decreased SPI-2 gene expression. Our results suggest a novel role for SIRT1 and SIRT3 in maintaining the intracellular <i>Salmonella</i> niche by modulating the mitochondrial bioenergetics and dynamics in the infected macrophages.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143762640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Honoring Robert E. W. Hancock: A Legacy of Innovation in Microbiology and Infectious Disease Research
IF 4 2区 医学
ACS Infectious Diseases Pub Date : 2025-04-01 DOI: 10.1021/acsinfecdis.5c0020710.1021/acsinfecdis.5c00207
Cesar de la Fuente-Nunez,  and , Jayanta Haldar*, 
{"title":"Honoring Robert E. W. Hancock: A Legacy of Innovation in Microbiology and Infectious Disease Research","authors":"Cesar de la Fuente-Nunez,&nbsp; and ,&nbsp;Jayanta Haldar*,&nbsp;","doi":"10.1021/acsinfecdis.5c0020710.1021/acsinfecdis.5c00207","DOIUrl":"https://doi.org/10.1021/acsinfecdis.5c00207https://doi.org/10.1021/acsinfecdis.5c00207","url":null,"abstract":"","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"11 4","pages":"796–798 796–798"},"PeriodicalIF":4.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143814509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toward a Bactericidal Oral Drug Combination for the Treatment of Mycobacterium abscessus Lung Disease.
IF 4 2区 医学
ACS Infectious Diseases Pub Date : 2025-04-01 DOI: 10.1021/acsinfecdis.4c00948
Jickky Palmae Sarathy, Min Xie, Chui Fann Wong, Dereje A Negatu, Suyapa Rodriguez, Matthew D Zimmerman, Diana C Jimenez, Ilham M Alshiraihi, Mercedes Gonzalez-Juarrero, Véronique Dartois, Thomas Dick
{"title":"Toward a Bactericidal Oral Drug Combination for the Treatment of <i>Mycobacterium abscessus</i> Lung Disease.","authors":"Jickky Palmae Sarathy, Min Xie, Chui Fann Wong, Dereje A Negatu, Suyapa Rodriguez, Matthew D Zimmerman, Diana C Jimenez, Ilham M Alshiraihi, Mercedes Gonzalez-Juarrero, Véronique Dartois, Thomas Dick","doi":"10.1021/acsinfecdis.4c00948","DOIUrl":"https://doi.org/10.1021/acsinfecdis.4c00948","url":null,"abstract":"<p><p>Treatment of <i>Mycobacterium abscessus</i> lung disease relies on underperforming drug combinations and includes parenteral, poorly tolerated, and bacteriostatic antibiotics. We posit that safe, oral, and bactericidal regimens are needed to improve cure rates and shorten treatment. Here, we combined oral representatives of three well-tolerated bactericidal drug classes, the β-lactam tebipenem (together with the β-lactamase inhibitor avibactam), the fluoroquinolone moxifloxacin, and the rifamycin rifabutin, and profiled the combination in vitro and in vivo. The combination potentiated bactericidal activity of its components against replicating <i>M. abscessus</i> and retained bactericidal activity against the nonreplicating, drug-tolerant form of the bacterium residing in surrogate caseum. When combined, the drugs retained the ability to induce lethal secondary effects associated with the β-lactam and fluoroquinolone, including cell wall and DNA damage, increased metabolism, and generation of reactive oxygen species. Thus, the triple-drug combination appears to exert two lethal punches while suppressing bacterial reprogramming to counter the drug-induced stresses, providing a plausible rationale for the enhanced kill effect. Addition of a bacteriostatic agent resulted in drug-specific patterns of interactions with regards to bactericidal activity reflected by the lethal secondary effects. The triple-drug combination also exerted a pronounced postantibiotic effect and reduced emergence of spontaneous resistant mutants. Collectively, this work provides a combination prototype for optimization and a profiling workflow that may be useful for the development of sterilizing regimens.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143762688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time-Dependent Inhibition of Leucyl-tRNA-Synthetase (LeuRS): Insight into Target Vulnerability
IF 4 2区 医学
ACS Infectious Diseases Pub Date : 2025-04-01 DOI: 10.1021/acsinfecdis.4c0101710.1021/acsinfecdis.4c01017
Mingqian Wang, YongLe He, Siobhan A. Cohen, Amanda R. Strohm, John D. Haley, Stephen G. Walker, M.R.K. Alley* and Peter J. Tonge*, 
{"title":"Time-Dependent Inhibition of Leucyl-tRNA-Synthetase (LeuRS): Insight into Target Vulnerability","authors":"Mingqian Wang,&nbsp;YongLe He,&nbsp;Siobhan A. Cohen,&nbsp;Amanda R. Strohm,&nbsp;John D. Haley,&nbsp;Stephen G. Walker,&nbsp;M.R.K. Alley* and Peter J. Tonge*,&nbsp;","doi":"10.1021/acsinfecdis.4c0101710.1021/acsinfecdis.4c01017","DOIUrl":"https://doi.org/10.1021/acsinfecdis.4c01017https://doi.org/10.1021/acsinfecdis.4c01017","url":null,"abstract":"<p >The postantibiotic effect (PAE) is the persistent suppression of microbial growth following the removal of antimicrobial therapy. In general, antibiotics that generate a PAE are dosed less frequently, and thus, the PAE has important implications for dosing regimens. PAEs can arise through several mechanisms, including the extended occupancy of the drug target following drug elimination, and the correlation between drug-target residence time and PAE provides insight into target vulnerability. To assess the vulnerability of <i>Escherichia coli</i> leucyl-tRNA synthetase (ecLeuRS), which is an essential enzyme in protein synthesis, the time-dependent inhibition of the enzyme was studied by the benzoxaborole class of compounds that inhibit LeuRS by forming a stable LeuRS-tRNA<sup>Leu</sup>-benzoxaborole adduct. Preincubation of epetraborole with ecLeuRS resulted in a decrease in the IC<sub>50</sub> value for enzyme inhibition from 38 to 3 nM, consistent with the slow formation of the final enzyme–inhibitor complex, and similar shifts in IC<sub>50</sub> were observed for three other benzoxaboroles. The benzoxaboroles generated short PAEs (&lt;1 h) in <i>E. coli</i>, however, the PAE values of AN3334 and epetraborole increased from 0.88 to 1.70–3 h when a sub-MIC concentration of the aminoglycoside tobramycin was included in the media. pSILAC revealed that the synthesis rate of ecLeuRS was reduced 1.6-fold in the presence of sub-MIC tobramycin, reinforcing the role that protein turnover plays in target vulnerability.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"11 4","pages":"977–985 977–985"},"PeriodicalIF":4.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143814516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SIRT1 and SIRT3 Impact Host Mitochondrial Function and Host Salmonella pH Balance during Infection
IF 4 2区 医学
ACS Infectious Diseases Pub Date : 2025-04-01 DOI: 10.1021/acsinfecdis.4c0075110.1021/acsinfecdis.4c00751
Dipasree Hajra, Vikas Yadav, Amit Singh and Dipshikha Chakravortty*, 
{"title":"SIRT1 and SIRT3 Impact Host Mitochondrial Function and Host Salmonella pH Balance during Infection","authors":"Dipasree Hajra,&nbsp;Vikas Yadav,&nbsp;Amit Singh and Dipshikha Chakravortty*,&nbsp;","doi":"10.1021/acsinfecdis.4c0075110.1021/acsinfecdis.4c00751","DOIUrl":"https://doi.org/10.1021/acsinfecdis.4c00751https://doi.org/10.1021/acsinfecdis.4c00751","url":null,"abstract":"<p >Mitochondria are important organelles that regulate energy homeostasis. Mitochondrial health and dynamics are crucial determinants of the outcome of several bacterial infections. SIRT3, a major mitochondrial sirtuin, along with SIRT1 regulates key mitochondrial functions. This led to considerable interest in understanding the role of SIRT1 and SIRT3 in governing mitochondrial functions during <i>Salmonella</i> infection. Here, we show that loss of SIRT1 and SIRT3 function either by shRNA-mediated knockdown or by inhibitor treatment led to increased mitochondrial dysfunction with alteration in mitochondrial bioenergetics alongside increased mitochondrial superoxide generation in <i>Salmonella-</i>infected macrophages. Consistent with dysfunctional mitochondria, mitophagy was induced along with altered mitochondrial fusion–fission dynamics in <i>S. typhimurium</i><i>-</i>infected macrophages. Additionally, the mitochondrial bioenergetic alteration promotes acidification of the infected macrophage cytosolic pH. This host cytosolic pH imbalance skewed the intraphagosomal and intrabacterial pH in the absence of SIRT1 and SIRT3, resulting in decreased SPI-2 gene expression. Our results suggest a novel role for SIRT1 and SIRT3 in maintaining the intracellular <i>Salmonella</i> niche by modulating the mitochondrial bioenergetics and dynamics in the infected macrophages.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"11 4","pages":"827–843 827–843"},"PeriodicalIF":4.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143814419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信